Invesco Ltd. Dynavax Technologies Corp Transaction History

Invesco Ltd.

$557 Billion
Q2 2025

A detailed history of Invesco Ltd. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Invesco Ltd. holds 985,980 shares of DVAX stock, worth $10.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

985,980

Previous 2,207,631 55.34%

Holding current value

$10.4 Million

Previous $28.6 Million 65.84%

% of portfolio

0.0%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$9.4 - $12.87 $11.5 Million - $15.7 Million	-1,221,651 Reduced 55.34%	985,980 $9.78 Million
Q1 2025 May 12, 2025	BUY	$12.39 - $14.4 $6.91 Million - $8.04 Million	558,046 Added 33.83%	2,207,631 $28.6 Million
Q4 2024 Feb 13, 2025	SELL	$10.28 - $13.66 $605,121 - $804,082	-58,864 Reduced 3.45%	1,649,585 $21.1 Million
Q3 2024 Nov 12, 2024	BUY	$10.05 - $11.61 $6.13 Million - $7.08 Million	609,845 Added 55.51%	1,708,449 $19 Million
Q2 2024 Aug 13, 2024	BUY	$10.73 - $12.58 $260,073 - $304,914	24,238 Added 2.26%	1,098,604 $12.3 Million
Q1 2024 May 14, 2024	BUY	$11.7 - $14.98 $1.16 Million - $1.49 Million	99,487 Added 10.21%	1,074,366 $13.3 Million
Q4 2023 Feb 12, 2024	SELL	$13.09 - $14.98 $815,349 - $933,074	-62,288 Reduced 6.01%	974,879 $13.6 Million
Q3 2023 Nov 13, 2023	SELL	$12.64 - $14.99 $2.42 Million - $2.87 Million	-191,630 Reduced 15.59%	1,037,167 $15.3 Million
Q2 2023 Aug 11, 2023	SELL	$9.85 - $13.17 $1.2 Million - $1.61 Million	-122,051 Reduced 9.04%	1,228,797 $15.9 Million
Q1 2023 May 12, 2023	BUY	$9.44 - $11.88 $400,303 - $503,771	42,405 Added 3.24%	1,350,848 $13.3 Million
Q4 2022 Feb 13, 2023	SELL	$10.27 - $13.29 $641,823 - $830,558	-62,495 Reduced 4.56%	1,308,443 $13.9 Million
Q3 2022 Nov 14, 2022	BUY	$9.93 - $17.44 $822,025 - $1.44 Million	82,782 Added 6.43%	1,370,938 $14.3 Million
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $5.37 Million - $9.25 Million	721,133 Added 127.18%	1,288,156 $16.2 Million
Q1 2022 May 16, 2022	BUY	$9.75 - $14.44 $85,897 - $127,216	8,810 Added 1.58%	567,023 $6.15 Million
Q4 2021 Feb 14, 2022	SELL	$13.17 - $20.94 $685,801 - $1.09 Million	-52,073 Reduced 8.53%	558,213 $7.85 Million
Q3 2021 Nov 15, 2021	BUY	$9.16 - $19.83 $5.23 Million - $11.3 Million	571,050 Added 1455.42%	610,286 $11.7 Million
Q2 2021 Aug 17, 2021	BUY	$7.25 - $10.99 $93,075 - $141,089	12,838 Added 48.63%	39,236 $386,000
Q1 2021 May 17, 2021	BUY	$4.57 - $11.18 $22,150 - $54,189	4,847 Added 22.49%	26,398 $260,000
Q4 2020 Feb 16, 2021	BUY	$3.73 - $5.6 $80,385 - $120,685	21,551 New	21,551 $96,000
Q1 2020 May 15, 2020	SELL	$2.27 - $6.2 $363,883 - $993,866	-160,301 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.46 - $6.93 $483,749 - $968,897	139,812 Added 682.38%	160,301 $917,000
Q3 2019 Nov 14, 2019	SELL	$2.69 - $4.85 $2,014 - $3,632	-749 Reduced 3.53%	20,489 $73,000
Q2 2019 Aug 14, 2019	SELL	$3.65 - $7.89 $2,642 - $5,712	-724 Reduced 3.3%	21,238 $85,000
Q1 2019 May 15, 2019	BUY	$7.08 - $12.09 $155,490 - $265,520	21,962 New	21,962 $161,000

Others Institutions Holding DVAX

# of Institutions

293

Shares Held

121M

Call Options Held

287K

Put Options Held

77.6K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.34B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account